What Is Most Important to Family Caregivers When Helping Patients Make Treatment-Related Decisions: Findings from a National Survey

Author:

Bechthold Avery C.1ORCID,Azuero Andres1,Puga Frank1ORCID,Ejem Deborah B.1ORCID,Kent Erin E.2ORCID,Ornstein Katherine A.3,Ladores Sigrid L.1ORCID,Wilson Christina M.14ORCID,Knoepke Christopher E.56ORCID,Miller-Sonet Ellen7,Odom J. Nicholas18ORCID

Affiliation:

1. School of Nursing, University of Alabama at Birmingham, Birmingham, AL 35294, USA

2. Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC 27599, USA

3. Center for Equity in Aging, School of Nursing, Johns Hopkins University, Baltimore, MD 21205, USA

4. Division of Gynecologic Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL 35233, USA

5. Division of Cardiology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

6. Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

7. CancerCare, New York, NY 10001, USA

8. Center for Palliative and Supportive Care, University of Alabama at Birmingham, Birmingham, AL 35233, USA

Abstract

Prioritizing patient values—who/what matters most—is central to palliative care and critical to treatment decision making. Yet which factors are most important to family caregivers in these decisions remains understudied. Using data from a U.S. national survey of cancer caregivers (N = 1661), we examined differences in factors considered very important by caregivers when partnering with patients in cancer treatment decision making by cancer stage and caregiver sociodemographics. Fifteen factors were rated on a 4-point Likert-scale from ‘very unimportant’ to ‘very important.’ Descriptive statistics were used to characterize caregiver factors and tabulate proportions of importance for each. Generalized linear mixed effect modeling was used to examine the importance of factors by cancer stage, and chi-square analyses were performed to determine associations between caregiver sociodemographics and the five most commonly endorsed factors: quality of life (69%), physical well-being (68%), length of life (66%), emotional well-being (63%), and opinions/feelings of oncology team (59%). Significant associations (all p’s < 0.05) of small magnitude were found between the most endorsed factors and caregiver age, race, gender, and ethnicity, most especially ‘opinions/feelings of the oncology team’. Future work is needed to determine the best timing and approach for eliciting and effectively incorporating caregiver values and preferences into shared treatment decision making.

Funder

Amgen, Merck, Regeneron, Eisai, Pfizer, Jazz, Astellas, and Glaxo-Smith Kline

Publisher

MDPI AG

Subject

Cancer Research,Oncology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3